Proteon Therapeutics (PRTO) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts PRTO Hot Sheet
Join SI Premium – FREE
Proteon Therapeutics (NASDAQ: PRTO) reported Q3 EPS of ($0.33), in-line with the analyst estimate of ($0.33).
For earnings history and earnings-related data on Proteon Therapeutics (PRTO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
